The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases

PLoS Pathog. 2015 Apr 23;11(4):e1004717. doi: 10.1371/journal.ppat.1004717. eCollection 2015 Apr.

Authors

Arturo Casadevall¹, Liise-Anne Pirofski²

Affiliations

¹ Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
² Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America; Department of Medicine (Infectious Diseases), Albert Einstein College of Medicine, New York, New York, United States of America.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Epidemics / prevention & control*
Hemorrhagic Fever, Ebola / epidemiology
Hemorrhagic Fever, Ebola / prevention & control*
Humans
Immunization, Passive / methods*

Grants and funding